HTP SW BH3 ED ALTO Implementation Plan Template FINAL
HTP SW BH3 ED ALTO Implementation Plan Template FINAL
Transformation Program
Implementation Plan Template and Milestone
Requirements
A. Implementation Plan 4
A. Implementation Overview 8
A. Overview of Intervention 9
B. Intervention Milestones 12
A. Overview 14
B. Milestone Requirements 15
E. Milestone Amendments 22
G. Payment 23
V. Program Timeline 24
Appendix A
PY3Q2 Milestone: 31
Appendix B
B. Assessment Tools 34
Within those priorities, hospitals are expected to implement interventions that address
quality measures across five HTP Focus Areas:
Section II of the Implementation Plan will include the hospital’s proposed organizational
approach to implementation. Section III will include the approach to implementation of each
intervention approved for participation via the Hospital Application. Hospitals must complete
Section III for each intervention.
Implementation Plans cover the five-year duration of the HTP. Hospitals will have an
opportunity to revisit their planned milestones and if needed, submit milestone amendments
and course corrections through the quarterly reporting process. The process for amending
milestones and for course correction is outlined in the HTP Milestones Requirements section
of this document.
Following the submission due date, the Department will have 20 business days to review and
score all Implementation Plans. At the conclusion of the review period, participating hospitals
may receive a request for information (RFI) or receive notification that the Implementation
Plan has been approved without RFI. Hospitals that receive an RFI will have 10 business days
to complete revisions within the Implementation Plan submission tool. Revised
implementation plans will be reviewed within 10 business days.
All hospital final implementation plans will be made public and posted online enabling
stakeholders to review how their hospitals plan to achieve the goals of the Hospital
Transformation Program.
Implementation Plans must earn passing scores for every pass / fail response to be approved.
Any question receiving a failing score during the review period will be returned to the
participant with specific instructions for revisions prior to resubmission.
A score of one (1) will be given to answers that need substantial revision. Scores of
one indicate that responses are either incomplete (do not address one or more part(s)
of the question asked) or do not demonstrate a satisfactory approach. Examples of
responses that would not demonstrate a satisfactory approach include:
A response to Question III.A.6. that does not include a plan for identifying and
engaging the intervention’s target population including addressing barriers to
recruitment and resulting gaps in engagement.
A response to Question III.A.7. that does not describe the resources that will
need to be re-purposed from other areas, built, acquired, or secured through a
partner or in some way.
A response that describes supporting documentation for an impact milestone
that is insufficient to validate its completion.
A score of two (2) represents a generally complete and satisfactory response to the
question (criteria for scores of one outlined above do not apply) with only limited
clarification or additional information needed to ensure responses are detailed enough
to provide the Department with a complete and accurate understanding of the
response. Any additional information or clarification needed will be specifically cited
by the Department.
A score of three (3) represents a complete, sufficiently detailed and acceptable
response and approach to the topic addressed (criteria for scores of one and two
outlined above do not apply).
Participants must earn scores of three (3) for every response included in their Implementation
Plan for it to be approved. Any question receiving a one (1) or two (2) during the initial
Implementation Plan review period will be returned to the hospital with specific instructions
for revision prior to resubmission. The Department will provide technical assistance aimed at
ensuring Implementation Plans receive approval.
A. Implementation Overview
II.A.1.a. Please fill out the following information for the hospital’s primary contact.
II.A.1.b. Please fill out the following information for the hospital’s secondary contact.
II.A.2. Governance Structure - Describe how the governance structure outlined in response to
Question 3 of the HTP Application will be engaged in the implementation and execution of the
hospital’s HTP participation. Address how leadership will ensure oversight and support,
including sign off/approval for resources, and address their role in the following functional
areas, as applicable:
Note from CHA: The below example addresses the key components of many hospitals’ HTP
governance structures. Please use this only as an example and refer to what you wrote in your
implementation plan. Your response should not be specific to the ED ALTO initiative, but
rather touch on the how the governance structure will support all HTP initiatives.
Please seek to limit response to 1,000 words.
A. Overview of Intervention
III.A.4. Is this an existing intervention (an intervention that the hospital previously planned
and is currently implementing or executing)? (See definition in the HTP Milestones
Requirements section of this document.)
Yes
No
III.A.5. The below chart is for principal internal and external administrative roles for this
intervention. If there are more than five individuals working on this intervention, please list
the five individuals with the greatest leadership roles or most time dedicated to this
intervention.
Note from CHA: The chart below has been updated to include POSSIBLE roles that might
be related to this intervention. For your application, please include the roles that are
most relevant to your organization.
III.A.6.b. Describe how individuals within the target population will be identified and engaged
in the intervention. (Please seek to limit response to 500 words.)
The target population will be identified and engaged in several ways. First, because
of the large target population for this intervention, physicians and nurses will be
trained extensively in limiting their opioid usage and increasing their ALTO usage for
all ED patients meeting this initiative’s inclusion criteria. Physicians and nurses will
be provided training on stigma and bias to better engage patients that come to the
ED with pain or existing OUD. Clinicians frequently consider opioids as the first line
of treatment for any patient the comes to the ED complaining of pain. However, the
only way to reduce opioid ordering in the ED is to shift the mindset of these
clinicians. By training clinicians to consider ALTOs when they hear about pain
instead of opioids will allow the target population to be engaged in this initiative.
Further, patients who come to the ED with OUD may be stigmatized or seen as “drug
seeking” by their clinicians. Again, training clinicians to work better with these
patients will ensure that they are not prescribed opioids and that those patients are
willing to return for care to the hospital when needed.
Further, the patient and family liaison will work closely with the project team to
develop appropriate patient education materials around opioids, opioid prescribing,
and the risk associated with opioid use. Patient materials will be created explaining
the risk of opioid usage and how pain relief may be provided as effectively in other
ways. Patients will be provided information on addiction to ensure patients feel
confident in a first line approach of ALTO for pain management (both
pharmaceutical and non-pharmaceutical) before considering opioids. The goal is to
ensure that patients feel confident that their pain will be managed using the safest
approach. Additionally, a process will be developed for printing and storing patient
education materials, as well as coaching patients on these materials to ensure all
patients, when appropriate, are able to receive these materials in a timely manner.
Although this intervention does not include recruitment per se, patients may be
resistant to taking ALTOs over opioids. In this case, the patient’s physician will
explain the hospital’s policy around opioid usage and will escalate any issues to the
ED Director as needed.
III.A.7.a. Describe what major functions and resources, supporting the initiative throughout
the course of implementation are already in place, or are not in place and will need to be re-
purposed from other areas, built, acquired, or secured through a partner or in some way.
Please address the following functional areas and resources, at a minimum, when responding 1:
III.A.7.b. Use the following space to describe the major functions and resources that are
already in place. (Please seek to limit response to 1,000 words.)
Our hospital already has an opioid stewardship program in place. The opioid stewardship
group meets monthly. The charter lays out the purpose of this group as well as specific
roles and responsibilities of the members. This group discusses opioid-related initiatives
throughout the hospital to ensure an organization-wide commitment to addressing the
opioid epidemic, as well as alignment with all related initiatives.
To ensure the appropriate capture of data, our hospital is partnering with the Colorado
Hospital Association (CHA) on this measure. We have a data representative that will work
closely with CHA to submit data. This partnership will allow us the ability to view our data
on a regular basis to make improvements to our efforts.
In 2019, CHA, The CO Medical Society and Colorado Consortium for Prescription Drug Abuse
Prevention launched an initiative to address the opioid epidemic – Colorado’s Opioid
Solution: Clinician United to Resolve the Epidemic (CO’s CURE). CO’s CURE brought
together diverse clinical specialties, all committed to resolving the opioid epidemic in CO
through the development of opioid prescribing guidelines that seek to treat patients’ pain
more effectively while reducing unnecessary exposure to opioids. Our hospital utilizes
OpiSafe which provides an integrated link to the CO CURE guidelines.
To support education, our hospital has a learning platform where physicians and nurses
complete required trainings. This platform includes education around safe opioid ordering.
Our organization has an education team that produces educational content and provides
trainings on a variety of clinical topic areas.
1
See section IV. Milestone Requirements, for more detailed definitions of each functional area.
III.A.7.c. Use the following space to describe the major functions and resources that are not
in place and will need to be re-purposed from other areas, built, acquired, or secured through
a partner or in some way. (Please seek to limit response to 1,000 words.)
Note from CHA: Below are examples of resources that may need to be acquired or
repurposed. Make sure to emphasize that your organization is utilizing the work from the
CO CURE initiative and will use these resources to align with and enhance your current
state. There is no one size fits all. The resources are there as guidance – it will have to be
integrated and adjusted to the current state/capabilities of your organization.
In 2017, CHA developed the Colorado Opioid Safety Pilot, which our hospital participated
in. The pilot study was conducted in 10 hospital EDs over a six-month span with a goal of
reducing the administration of opioids in those EDs by 15%. Our hospital will re-purpose any
lessons learned in this pilot study and apply them to the HTP SW-BH3 measure
specifications. We will partner with CHA on the data process as outlined in the CHA SW-BH3
Data Manual in order to comply with the data requirements of the HTP measure. This data
will also be visualized and utilized to drive continuous improvement.
Our hospital will need to add a focus on ED ALTO to the opioid stewardship group. We will
do this by adding a standing agenda meeting to the opioid stewardship meetings that
specifically address the ED ALTO initiative.
Although we have a patient and family engagement council, we will need to make sure we
have a representative specifically weighing in on patient and family engagement as it
relates to opioid stewardship to ensure this initiative is understood by patients and
families. We will also have this representative join the CHNE process to ensure they
understand the needs of the community regarding OUD and opioid usage in general.
We will need to utilize our existing IT and data resources to develop or update clinical
pathways for each pain condition, and we will need to update existing order sets to ensure
they align opioid and ALTO recommendations.
Lastly, we will need to update educational materials for staff to ensure they align with the
goals of the ED ALTO initiative. We will utilize the checklist, education modules, and other
resources that are available from CHA as a starting point to surface what can be used and
what needs to be re-purposed for our organization.
III.A.8.a. Describe any major challenges and risks to intervention implementation and how the
hospital will mitigate those challenges and risks. In the response, specifically address the
following areas:
Workforce;
Budget;
Health Information Technology;
Regulatory Barriers; and
Challenges related to engaging difficult-to-reach populations.
III.A.8.b. Use the following space to describe any major challenges and risks to intervention
implementation. (Please seek to limit response to 750 words.)
There are several challenges that we anticipate relating to our workforce. Both faculty and
staff have many competing priorities and, although we would like them to prioritize this
initiative, we recognize that it can put an incredible burden on all employees to plan,
develop materials for, train staff, and implement a new initiative in an already
overwhelmed area like the ED. These many priorities can lead to additional administrative
responsibilities for clinicians and even possible clinician burnout, both negatively impacting
patient engagement. Additionally, the culture of the organization always poses a threat to
new initiatives. Clinicians are used to prescribing opioids as a first line of treatment and
changing that habit will take time. Further a lack of knowledge around how to interpret
data and conduct PDSA cycles may limit the efficiency with which we are able to target
areas for improvement and make effective changes. Other challenges include a lack of
knowledge around current opioid prescribing guidelines and non-pharmacologic ALTOs or a
reluctance to use new ALTOs like Ketamine and Lidocaine, staff turnover, and lack of
leadership engagement.
Resource constraints further pose a challenge to this initiative. Lack of funding to pay
clinicians overtime to attend trainings or lack of funding to develop training poses a risk to
properly training staff for this initiative. Further, a lack of funding for new or innovative
ALTO treatments or therapies, like music therapy, could limit our hospital’s ability to fully
implement this initiative.
Health Information Technology and regulatory barriers likewise pose challenges for this
initiative. Our hospital has struggled previously to run reports from our EHR in a timely
manner. Additionally, our PDMP is an incredibly valuable tool in improving our opioid
stewardship, but our current PDMP is “pull” instead of “push” meaning clinicians must
remember to check the PDMP for each patient. Further, the PDMP only captures patients in
Colorado and will not be useful for patients visiting from out of state. Lastly, the inability
to interpret any data that is generated poses a potential challenge.
III.A.8.c. Use the following space to describe how the hospital will mitigate the challenges
and risks described above. (Please seek to limit response to 750 words.)
To reduce the burden on clinicians from competing priorities that may lead to excessive
administrative responsibilities and burnout, we will utilize leadership to stress the
To address the culture of opioid prescribing we will share with all faculty and staff the role
clinicians can play in reducing opioids in the community. We will also employ change
management techniques, such as involving every employee in this initiative, creating strong
support from leadership, and providing compelling data on the impact such programs can
have on patients and their families. We will also solicit feedback regularly from staff to
understand the challenges they are facing in changing their ordering habits.
To address the lack of knowledge around data and quality improvement we will work
closely with our quality improvement team to help ED staff better understand the data and
how to perform PDSA cycles. We will also provide training to staff on quality improvement
principles and the quality improvement team will utilize quality improvement worksheets
for each PDSA cycle such as those that are available on the Colorado Hospital Association
website here.
To address the lack of knowledge around current opioid prescribing guidelines and non-
pharmacologic ALTOs we will provide training to ED faculty and staff. To address a
reluctance to use new ALTOs like Ketamine and Lidocaine, we will provide training from
organizations who have already implemented this initiative to speak to their experience,
such as those provided in the Emergency Medical Minute podcast series here.
To mitigate complications that come with staff turnover, we will require all new staff to
complete online trainings related to the ED ALTO initiative, such as those that are available
on the Colorado Hospital Association website here.
To mitigate issues related to a lack of funding for training, this initiative will utilize the
many training materials that are already available free of cost and will emphasize shorter,
more effective trainings so clinicians do not need to take substantial amounts of time out of
their days to complete trainings. We will also emphasize coaching by ED champions to make
clinicians aware of how they can limit opioid ordering.
To address possible delays in data reports, this initiative will have an IT coordinator
specifically focused on this project. We will also utilize reports and interpretations of those
reports from CHA, so we do not need to dedicate internal resources to doing so.
To address the possible stigmatization of patients who use drugs, we will require all staff to
participate in stigma and bias training such as the Dell Medical School Modules here.
To mitigate the risk that patient educational materials may be insensitive or irrelevant to
the patient population, all new materials that are developed will be brought to the patient
and family engagement council for approval.
III.A.9. Describe how this intervention will benefit from the hospital’s ongoing Community and
Health Neighborhood Engagement efforts. (Please seek to limit response to 500 words.)
The ongoing CHNE process allows our hospital to better understand the needs of our
community and connect with community partners. Our CHNE engaged police officers, local
family practitioners, dentists, the health department, and many others. By hearing from
these diverse groups of stakeholders we were able to understand the needs of our
community beyond the walls of our hospital. For instance, the perspective of the police
department is invaluable particularly when it comes to reducing opioid prescribing, which
leads to greater opioid usage in the community. The police department sees daily that the
community is struggling with substance use disorders and are already acting as valuable
partners in this initiative aimed at reducing opioid use in the community. Further, primary
care providers are crucial to our hospital’s ability to limit opioid prescribing and increase
the use of ALTOs. If patients are receiving opioid from their primary care providers it may
be more challenging to treat their acute or chronic pain in the ED. Working with primary
care practitioners, dentists, and others allows a diverse group of health care providers to
work together to not only reduce the use of opioids but support one another in determining
the best approach to challenging cases and addressing a culture that still often stigmatizes
individuals who use drugs.
B. Intervention Milestones
Hospitals must propose and record in the Implementation Plan submission tool one milestone
in both Quarters 2 and 4 (Q2 and Q4) for each Program Year (PY) starting with PY2Q2 (Jan. –
Mar. 2023). Milestones should be discrete tasks that, when completed, have an easily
identifiable, quantifiable, and definable goal that has been reached or action that has been
completed. The milestones established must be completed by the end of the quarter for
which the milestone is applicable (Q2 or Q4).
The submission tool will guide hospitals through recording milestones per intervention for
each applicable program year quarter. Hospitals will indicate the milestone phase and
whether it is an impact milestone. Interventions will be prepopulated in the submission tool
based on the hospital’s approved HTP Application.
Note from CHA: the below are tasks your organization will likely need to meet to successfully
launch the ED ALTO initiative, however, some of these you may have already implemented.
Please modify the below tasks to align with your organizational needs, resources, and typical
processes. Remember that multiple tasks can make up one milestone. See the CHA website
here for more details on pre-launch activities.
III.B.1. Please answer the following questions with information related to this intervention’s
milestone.
Yes
No
III.B.3.a. Please indicate which Functional Area(s) applies to this milestone. Select all that
apply. Impact milestones must include all Functional Areas.
“Milestones” are defined as key activities or deliverables that reflect successful completion of
key steps toward the participant’s intervention and subsequent achievement of HTP goals.
Milestones should be important to the hospital’s overall development process. Milestones should
be discrete tasks that, when completed, have an easily identifiable, quantifiable, and definable
goal that has been reached or action that has been completed. Each milestone, when completed,
will require the submission of the supporting documentation described in the Implementation
Interventions and their accompanying milestones should be developed with an anticipated date of
reaching their full scale or near-to-full scale levels of impact by the conclusion of PY3 (Oct. 2023
– Sept. 2024). This will be demonstrated by the inclusion (and achievement) of an impact
milestone as the final milestone for the Planning and Implementation phase as outlined below.
HTP participants applying to use an existing intervention should submit milestones at the same
level of definition as those entities that are applying to use new interventions, but those
milestones must be proposed at an accelerated timeline as outlined below.
Starting in PY1 (Oct. 2021 – Sept. 2022), participating hospitals will be required to submit
quarterly reports that address progress on milestones and associated interim activities related to
each HTP intervention’s progress. Milestones will be reported and at-risk dollars evaluated semi-
annually, with associated “interim activities” reported in the intervening quarters.
“Interim activities” should track progress towards intervention milestones. Payment is not
specifically tied to the successful completion of interim activities. However, interim activity
progress toward completion of milestones must be reported and the Department will use interim
activities to understand overall implementation progress.
As transformation activities are inherently dynamic, the HTP will allow each participant to submit
proposed milestone amendments along with their HTP reports for Q2 and Q4. Each amended
milestone will need to be submitted along with justification for the change. Hospitals will also
have opportunities for course corrections as outlined in further detail below.
B. Milestone Requirements
The HTP is built around three primary phases for measuring progress. Milestones should be
developed and submitted under phases one and three below (phase two is comprised only of
performance metrics):
1. “Planning and Implementation Phase”: These milestones should document the process
through which the participant will complete all necessary preliminary activities (e.g.
preparation, gap assessments) that support implementation. The final set of this phase’s
milestones should focus on implementation activities resulting in the intervention’s
inception.
Each milestone occurring during the Planning and Implementation phase must also be identified
as affecting one or more of the following “Functional Areas.”:
For example, if the intervention is based on increasing Social Needs screeners where the target
population is all inpatient admission patients, impact milestone supporting documentation could
include:
People: The total number of individuals trained to properly administer the screener and
assigned to screen;
Process: The policies and protocols for implementing and administering the new screener;
Technology: A screenshot of the system that has been implemented or updated to accept
screener data;
Patient Engagement / Target Population: Aggregated, de-identified thirty day results of
health screener for all patients in the inpatient setting.
Planning and Implementation milestones for new interventions should be completed no later than
PY3Q4 (Jul. – Sept. 2024) and Continuous Improvement milestones should begin no later than
PY4Q2 (Jan. – Mar. 2025). However, hospitals may complete Planning and Implementation
milestones at any point prior to PY4Q2 (Jan. – Mar. 2025) and begin reporting Continuous
Improvement milestones.
For existing interventions, it is expected that hospitals will reach their full scale at an
accelerated pace. “Existing interventions” are those interventions the hospital had implemented
or was implementing on the day it submitted the HTP Application. The hospital may propose
planning milestones specific to the enhancement of the intervention to meet HTP requirements
(including impact milestones) and implementation milestones. However, final Planning and
Implementation phase milestones for existing interventions must occur no later than PY3Q2 (Jan.
– March. 2024). Similarly, the hospital should propose Continuous Improvement milestones to
begin no later than PY3Q4 (July – Sept. 2024). Hospitals proposing to leverage existing
interventions that are already at full scale at the beginning of the HTP should include an impact
milestone as the first and only Planning and Implementation milestone for such interventions
prior to moving on to Continuous Improvement milestones.
The tables below map the Implementation Plan milestone inputs expected for the course of the
program, depending on whether the intervention is new, existing, or relates to the Hospital Index
Measure.
Milestone Milestone
Functional Area(s) Functional Areas
and Description and Description
Q2 N/A N/A Milestone Milestone
Jan - Description Description
Continuous March
Improvement
Phase Q4 N/A N/A Milestone Milestone
Milestones July - Description Description
Sept
*Impact Milestones for New interventions must be completed by the end of PY3 (Sept. 2024) and must address
all Functional Areas. Continuous Improvement Phase Milestones must begin no later than PY4Q2 (Jan. – Mar.
2025).
* Impact Milestones for existing interventions must occur prior to PY3Q4 (Jul. – Sept. 2024). Continuous
Improvement milestones must begin prior to PY4 (Oct. 2024 – Sept. 2025).
Indicates it was completed in a timely manner (e.g. agendas from meetings that occurred
within the timeframe of the milestone);
Substantiates that the milestone was completed (e.g. submission of a gap assessment that
was developed in pursuing a milestone calling for the development of a gap assessment).
When milestones are created and submitted in Implementation Plans, the Department will
evaluate each to validate its appropriateness for the HTP participant’s intended intervention
goals. The Department will review and approve or request revision to all submitted milestones
based on the following criteria:
When the Department completes its evaluation of submitted milestones as part of the
Implementation Plan review, it will score based on the one to three (1-3) scoring rubric and may
offer suggested revisions. Hospitals will have an opportunity to accept the milestone revisions if
present or propose a new milestone.
All quarterly reports will be evaluated based on, but not limited to, the following criteria:
Department notifies participant that scores received for Report submission due date + 21
quarterly reporting are available on CPAS portal business days
“Course correction plans” must provide insights into the root causes of a missed milestone and
detail the process the program participant intends to pursue to either complete the missed
milestone as previously defined or provide insight as to why the missed milestone will not or
should not be completed. Course correction plans must also provide operational insights into how
future milestones associated with the intervention will be completed by their previously intended
deadlines. Part of the hospitals’ plan for correcting an intervention’s course may involve
amending future milestones. While the course correction plan could discuss amending future
milestones as part of the way forward, the course correction plan is not the mechanism by which
milestones are amended. All milestone amendments must be submitted as an official milestone
amendment, as discussed in the previous section of this document. As a result, if a course
correction plan discusses milestone amendments which are not separately submitted as milestone
amendments, no changes to the hospital’s milestones will be recognized. As a reminder, as
outlined above, milestones may also be amended prospectively through reports for Q2 and Q4 and
there is no limit to how often a hospital may prospectively amend milestones.
G. Payment
HTP participants will be paid monthly throughout the term of the program. Payments of at-risk
dollars made for Q4 of the ramp up period (Application Period) will be determined by the
participant’s successful completion of their Program Application. Payments of at-risk dollars
made for PY1 will be determined by the participant’s successful completion of their
Implementation Plan and in part, on successfully reporting in each participant’s quarterly filings.
Payments of at-risk dollars for PY2 to PY5 (Oct. 2022 – Sept. 2026) will, in part, be based on
ongoing reporting of milestones and interim activities in each participant’s quarterly filings.
37
I. Hospital Index Measure: Background
The SW-COE1 Hospital Index Measure is a statewide measure of avoidable care across
procedural episodes. A hospital’s index score will be compared to a baseline index score.
The Hospital Index Measure is designed to stand up and support a continuous learning
environment, which may then be leveraged for other interventions or hospital processes.
Hospitals can best address this measure by following the laid out guidance, particularly for
reporting performance for the impact milestone for PY2Q2 (Jan. – Mar. 2023) and the
continuous learning and improvement milestones starting PY2Q4 (Jul. – Sept. 2023) until
the end of the program. There are pre-defined milestones to support achievement of the
Hospital Index Measure.
The Department will use the following questions and prompts when evaluating Hospital
Index milestones. This includes questions to investigate a hospital’s current capacity to
run effective quality improvement (QI) initiatives through the lens of applicable functional
areas and help uncover gaps that could deter from success in the HTP’s continuous
improvement phase.
b. Does your hospital offer protected time to quality leadership or frontline staff to
engage in quality improvement initiatives?
c. How does the hospital engage quality leaders in institutional quality initiatives?
e. How does your hospital disseminate performance data related to quality initiatives
to staff in both quality leadership positions and frontline positions? (i.e. accessible
dashboards, report distribution, presentations at regularly scheduled series or
huddles, public postings in patient accessible areas, etc.).
b. What gaps exist in your current quality structure that you will need to address to
successfully run a continuous quality improvement effort for this measure?
2
For more information and helpful resources, please see Appendix B of this document.
b. Is the analytics team centralized? Does this team primarily focus on hospital level
measures? Are additional analysts available to assist local quality initiatives?
c. The following procedure codes in the chart below are used to calculate
performance in the Hospital Index measure. After consulting with your analytics
team, what is the feasibility of monitoring the frequency of these procedures in a
recurring report by service area?
b. Describe how the hospital will utilize its Hospital Index dashboard and information
to monitor PAC performance and equity for patients by reviewing disaggregated
data by race, ethnicity, language, gender, etc., and how that could impact how
the hospital approaches patient experience, delivery of care, outcomes, or
satisfaction.
a. In the chart below, list the top 5 episodes with the greatest weighted impact on
your Hospital Index score and indicate what type of action is needed to achieve the
state set benchmark (i.e. Maintain performance or improve)?
Top 5 Episodes Maintain or Improve Performance?
1
2
3
4
5
c. Consider factors such as the procedure code or DRG, provider type, service
location, and specific rendering/attending providers that drive high/low PAC in
this episode to answer the following questions:
1. What is driving PAC?
2. What is contributing to low PAC?
a. Proposed approach for each episode, please answer the following questions to
identify and assess stakeholders that you must engage to implement a quality
improvement initiative.
a. Please describe the approach to the quality initiative(s) required to improve your
index score. Describe what continuous learning and improvement
model(s)/strategies you will be implementing (rapid cycle improvement, etc.).
Below are suggested ways to approach this:
1. Describe your next intervention indicating how long each test cycle will last
and how many tests you hope to complete during the next reporting cycle.
2. Comment on the scope of your intervention with the following considerations:
o Where will the intervention take place?
o What population will it focus on?
o What is the size of the population it will affect?
o Can you ensure the first test of your intervention has a minimized
scope?
3. What will you measure to know that you have successfully implemented the
intervention for your initial rapid cycle test of change?
4. What will you measure to know if your intervention led to an improvement?
(i.e. describe a proxy measure to assess progress towards the state set
benchmark).
1. Describe your next intervention cycle and what you plan to complete during the
next reporting cycle.
2. Please describe your current continuous quality improvement strategy to improve
or maintain the top 5 episodes impacting your Hospital Index Score.
3. Please describe how you plan to either continue with the current strategy or adapt
it to achieve the desired outcome in your Hospital Index Score.
4. What and how do you plan to report out to key stakeholders regarding what was
learned during the next cycle?
44
I. Quality Improvement Resources
As part of the continuous learning and improvement milestones, hospitals implement and
describe their strategies to evaluate or improve their performance. A quality improvement
program includes activities, such as monitoring, analyzing, and improving the quality of
processes, aimed at specific health outcomes in a healthcare organization. The following
sections detail additional resources on conducting current state assessments and planning out
the continuous improvement process:
Models for Improvement
Assessment Tools
Stakeholder Engagement Toolkits
Care Coordination and Service Delivery Best Practices
While these resources are not meant to be exhaustive, hospitals may consider this list to
assist in overall quality improvement initiatives.
A. Models for Improvement
1. Resource: Practice Facilitation Handbook, AHRQ. Accessed online:
https://www.ahrq.gov/ncepcr/tools/pf-handbook/index.html
Key Takeaways: This worksheet is for primary care staff to help plan a quality
improvement (QI) Plan-Do-Study-Act (PDSA) cycle, outlining the QI goals and how the
practice will try to reach them, as well as providing space for actual outcomes and
analysis of next steps.
Key Takeaways: This webpage includes guidance on how to write a great aim
statement. The aim statement is a clear, explicit summary of what your team hopes to
achieve over a specific amount of time including the magnitude of change you will
achieve. The aim statement guides your work by establishing what success looks like.
6. Resource: Worksheet for Developing Your Quality Improvement Project, John Hopkins
Medicine. Accessed online:
https://www.hopkinsmedicine.org/armstrong_institute/_files/patient
%20safety%20and%20quality%20improvement%20project%20tools/
spirit_toolkit/module%203_worksheet%20for%20qi%20project.pdf
B. Assessment Tools
1. Resource: Organizational Quality Assessment Tool, HEALTHQUAL. Accessed online:
https://healthqual.ucsf.edu/sites/g/files/tkssra931/f/HEALTHQUAL
%20OA_February%202018.pdf
2. Resource: Registries for Evaluating Patient Outcomes: A User's Guide: 4th Edition,
AHRQ. Accessed online:
https://effectivehealthcare.ahrq.gov/products/registries-guide-4th-edition/
users-guide
Key Takeaways: The fourth edition of the AHRQ publication, "Registries for Evaluating
Patient Outcomes: A User's Guide," is a reference handbook that provides best
Key Takeaways: This resource library is a collection of care decision guides, scripting,
governance documents, tools, risk assessments, and evaluation forms that are critical
to the success of operating population health initiatives. This library includes ready-to-
use resources you can download and tailor to optimize your initiatives.
Key Takeaways: AAFP’s EveryONE Project promotes diversity and addresses SDOH to
advance health equity in all communities. The initiative offers education and
resources to help you advocate for health equity, promote workforce diversity, and
collaborate with other disciplines and organizations to reduce harmful disparities. This
toolkit offers strategies for use in one’s practice and community to improve patient
health and help individuals thrive.
6. Resource: Protocol for Responding to and Assessing Patients’ Assets, Risks, and
Experiences (PRAPARE), National Association of Community Health Centers. Accessed
online: https://www.nachc.org/research-and-data/prapare/
Key Takeaways: The Protocol for Responding to and Assessing Patients’ Assets, Risks,
and Experiences (PRAPARE) is a national effort to help health centers and other
providers collect the data needed to better understand and act on their patients’
social determinants of health. The PRAPARE assessment tool consists of a set of
national core measures as well as a set of optional measures for community priorities.
As providers are increasingly held accountable for reaching population health goals
while reducing costs, it is important that they have tools and strategies to identify the
upstream socioeconomic drivers of poor outcomes and higher costs.
Key Takeaways: Effective planning and decision-making for improving the health of a
community requires good information about current health status and factors that will
influence that health status. This document identifies the metrics - the population
health outcomes and important risk and protective factors - that, when taken
together, can describe the health of a community and drive action. Selection of these
metrics reflects the weight of professional and academic judgment over the past three
decades.
8. Resource: Blueprint for Complex Care, The National Center for Complex Health &
Social Needs. Accessed online:
https://www.nationalcomplex.care/wp-content/uploads/2019/03/Blueprint-
for-Complex-Care_UPDATED_030119.pdf
Key Takeaways: The Blueprint for Complex Care is a guide for advancing the field of
complex care. NCCHSN gathered diverse, far-reaching perspectives through reviews of
published literature, interviews, surveys, and an expert convening to develop a
comprehensive understanding of the current state of complex care, and to shape our
recommendations for strengthening the field. It outlines the current state of complex
care and includes recommendations for the future.
Key Takeaways: This toolkit will guide you through the process of planning and
executing stakeholder mapping. In addition to a step-by-step process, this toolkit also
contains helpful tips and important considerations in the text boxes placed throughout
the document.
Key Takeaways: Stakeholder mapping is a tool used to analyze and prioritize the
engagement of stakeholders when you are planning to implement an initiative. This
tool will help you and your team generate information about stakeholders to
understand their interests and assess their influence in order to successfully
implement and sustain a new initiative.
Key Takeaways: This IHI white paper outlines methods and opportunities to better
coordinate care for people with multiple health and social needs, and reviews ways
that organizations have allocated resources to better meet the range of needs in this
population. There is special emphasis on the experience of care coordination with
populations of people experiencing homelessness.